Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARA | Q07869 | 7/20 | 0.49 |
| ▸ | PPARG | P37231 | 4/20 | 0.49 |
| ▸ | ACHE | P22303 | 3/20 | 0.46 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.43 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.42 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.42 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16124570 | 0.92 | ALOX5 (0.52) | PPARAPPARGACHEALOX5 | |
| SCHEMBL16124597 | 0.85 | ACHE (0.48) | PPARAPPARGACHECYP2D6 | |
| SCHEMBL16124578 | 0.83 | SPHK1 (0.52) | SPHK1 | |
| SCHEMBL16124599 | 0.83 | PPARA (0.48) | PPARAPPARGACHECYP2D6SPHK1 | |
| SCHEMBL13416241 | 0.83 | ACHE (0.41) | PPARAPPARGACHECYP2D6MTNR1A | |
| SCHEMBL13396358 | 0.81 | ALOX5 (0.42) | PPARAPPARGACHEALOX5MTNR1A | |
| SCHEMBL13416257 | 0.80 | ACHE (0.43) | ACHEALOX5 | |
| SCHEMBL1790266 | 0.79 | PPARA (0.57) | PPARAPPARGACHECYP2D6MTNR1A | |
| SCHEMBL16124584 | 0.79 | ACHE (0.49) | PPARAPPARGACHEALOX5 | |
| SCHEMBL13396357 | 0.78 | ALOX5 (0.44) | ACHEALOX5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140288142-A1 | NITRIC OXIDE DONOR COMPOUNDS | NICOX SA (FR) | 2014-09-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140288142-A1 | NITRIC OXIDE DONOR COMPOUNDS | NOS3, NOS2, NOS1 | PPARA 2870/4885PPARG 3056/4885ACHE 394/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.